Quality of life and survival in elderly metastatic castration-resistant prostate cancer (mCRPC) patients (Pts) treated with docetaxel

Paredero Perez, I.Arnal, M.Lorente, D.Girones Sarrio, R.Lozano Mejorada, R.Romero Laorden, N.Llacer Perez, C.Castro Marcos, E.Olmos, D.Sanchez Hernandez, A.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/27077enQuality of life and survival in elderly metastatic castration-resistant prostate cancer (mCRPC) patients (Pts) treated with docetaxelconference outputopen access10.1016/j.annonc.2020.08.8991569-8041http://www.annalsofoncology.org/article/S0923753420408956/pdf573469100637